β-Arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3

PH McDonald, CW Chow, WE Miller, SA Laporte… - Science, 2000 - science.org
PH McDonald, CW Chow, WE Miller, SA Laporte, ME Field, FT Lin, RJ Davis, RJ Lefkowitz
Science, 2000science.org
β-Arrestins, originally discovered in the context of heterotrimeric guanine nucleotide binding
protein–coupled receptor (GPCR) desensitization, also function in internalization and
signaling of these receptors. We identified c-Jun amino-terminal kinase 3 (JNK3) as a
binding partner of β-arrestin 2 using a yeast two-hybrid screen and by
coimmunoprecipitation from mouse brain extracts or cotransfected COS-7 cells. The
upstream JNK activators apoptosis signal–regulating kinase 1 (ASK1) and mitogen …
β-Arrestins, originally discovered in the context of heterotrimeric guanine nucleotide binding protein–coupled receptor (GPCR) desensitization, also function in internalization and signaling of these receptors. We identified c-Jun amino-terminal kinase 3 (JNK3) as a binding partner of β-arrestin 2 using a yeast two-hybrid screen and by coimmunoprecipitation from mouse brain extracts or cotransfected COS-7 cells. The upstream JNK activators apoptosis signal–regulating kinase 1 (ASK1) and mitogen-activated protein kinase (MAPK) kinase 4 were also found in complex with β-arrestin 2. Cellular transfection of β-arrestin 2 caused cytosolic retention of JNK3 and enhanced JNK3 phosphorylation stimulated by ASK1. Moreover, stimulation of the angiotensin II type 1A receptor activated JNK3 and triggered the colocalization of β-arrestin 2 and active JNK3 to intracellular vesicles. Thus, β-arrestin 2 acts as a scaffold protein, which brings the spatial distribution and activity of this MAPK module under the control of a GPCR.
AAAS